Purchases and Sales Made in Q2 2024 in Iovance Biotherapeutics, Inc. (IOVA)
This table provides information about the institutional ownership of Iovance Biotherapeutics, Inc. (IOVA) during Q2 2024. The information is specifically focused on institutions that hold shares of IOVANCE BIOTHERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-868K- 78.1% |
$6.75M - $12.3M
|
243K
$2.26M
|
|
|
Aug 12, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-947K- 21.6% |
$7.37M - $13.4M
|
3.44M
$31.9M
|
|
|
Aug 14, 2024
Q2 2024
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-1M- 28.69% |
$7.8M - $14.2M
|
2.49M
$23.1M
|
|
|
Aug 13, 2024
Q2 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.16M- 30.69% |
$9.03M - $16.5M
|
2.62M
$24.3M
|
|
|
Aug 14, 2024
Q2 2024
|
Summit Partners Public Asset Management, LLC
Boston, MA |
SELL
|
- |
-1.41M- 47.56% |
$11M - $20M
|
1.56M
$14.4M
|
|
|
Aug 14, 2024
Q2 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-1.45M- 89.72% |
$11.3M - $20.6M
|
166K
$1.54M
|
|
|
Aug 14, 2024
Q2 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-1.7M- 72.12% |
$13.2M - $24.1M
|
656K
$6.08M
|
|
|
Aug 14, 2024
Q2 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-1.79M- 33.89% |
$13.9M - $25.3M
|
3.48M
$32.3M
|
|
|
Aug 13, 2024
Q2 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-2.33M- 71.69% |
$18.1M - $33.1M
|
920K
$8.53M
|